Trial intelligence / Profile preview

Ketorolac for prevention of postoperative shivering after cholecystectomy

IRCT2016080229162N1Phase 3Completed

Sponsor
Ardabil University of Medical Sciences
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ketorolac in postanesthetic shivering (PAS) (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Incidence of postoperative shivering. Started Apr 2016; status: completed.

02

Drugs

ketorolac
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT2016080229162N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016080229162N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call